> Skip repeated content
photo of Erica Tafuro, MD

Erica Tafuro, MD

Anesthesiology
phone icon

About Dr. Tafuro

Dr. Erica Tafuro is a board certified anesthesiologist at Hospital for Special Surgery specializing in regional anesthesiology. Dr. Tafuro completed her anesthesiology residency at Montefiore Medical Center where she also served as chief resident in her final year. After residency, she completed a fellowship in regional anesthesia and acute pain medicine at HSS, accepting a position to return as an attending physician.

As a fellow at HSS, Dr. Tafuro had an academic focus in Point of Care Ultrasound (PoCUS) and incorporated this skill set with her interest in Global Health. Together with the Global Musculoskeletal Health Equity Division (GMHED), Dr. Tafuro piloted the PoCUS training program at Osmania General Hospital in Hyderabad, India to provide a standard for which PoCUS training occurs in a limited resource setting. The goal of this initiative was to closely follow the Global Regional Anesthesia Curricular Engagement (GRACE) study, pioneered by GMHED to improve anesthesia care and decrease perioperative morbidity for faster diagnosis and treatment of life-threatening conditions with PoCUS in a cost-effective way. Additionally, Dr. Tafuro has a collaboration with the HSS Lifestyle Medicine program for early identification and intervention of frailty in patients with increased risk of postoperative complications and prolonged hospital stays.

Departments

Special Expertise

Regional anesthesia and acute pain medicine

Patient Stories

Insurance

If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.

Credentials

Appointments

Assistant Attending Anesthesiologist, Hospital for Special Surgery
Clinical Instructor Anesthesiology, Weill Cornell Medical College

Affiliations

American Board of Anesthesiology
American Society of Regional Anesthesia
New York Society of Anesthesiologists

Certification

American Board of Anesthesiology, 2023
Diagnostic Point of Care Ultrasound, American Society of Anesthesiology, 2023
Basic Focus Assessed Transthoracic Echo (FATE) certification, 2022

Awards

Chief Resident, Montefiore Medical Center, 2021-2022
Humanism in Medicine Award, Montefiore Medical Center, 2022

Education

Medical: George Washington University School of Medicine and Health Sciences, 2018
Internship: Internal Medicine, Mount Sinai School of Medicine, Elmhurst Hospital Center; New York, NY, 2019
Residency: Anesthesiology; Montefiore Medical Center; New York, NY, 2019-2021
Chief Anesthesiology Resident; Montefiore Medical Center; New York, NY, 2021-2022
Fellowship: Regional Anesthesia & Acute Pain Management: Hospital for Special Surgery, New York, NY; 2023

State Licensure

Languages

English

Publications by Dr. Tafuro

Selected Presentations

Lucia L, Tafuro E, Pakala S, & Thakkar N. "Development of a Needs Assessment for Point-of-Care Ultrasound Curriculum in Limited Resource Setting." Poster presentation. ASRA, Hollywood, FL. April 20-22, 2023.

Research

Industry Relationships

Industry Relationships

HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.

As of September 18, 2023, Dr. Tafuro reported no relationships with the healthcare industry.

HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.